Insider transactions

EDGAR

CARING BRANDS, INC.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-21.

Open-market purchases (code P)
0 transactions, — shares
Open-market sales (code S)
0 transactions, — shares

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–16 of 16

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-10-06 Filed 2026-10-16WILSON GLYNN Director · Officer: Chief Executive Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (75,000) — exercise price 1.13
Acquired (A)75,0000—747,592Direct (D) No
F1, F2, F3
  • F1 On October 6, 2026, at the recommendation of the Issuer's Compensation Committee, the Issuer's Board of Directors approved this option grant under the Company's equity incentive plan.
  • F2 The options vested immediately on October 6, 2026.
  • F3 The number of shares of common stock beneficially owned following the reported transaction also includes the Reporting Person's ownership of (i) 126,720 restricted stock units of common stock of the Issuer of which zero have vested, (ii) 45,872 restricted stock units of common stock of the Issuer of which zero have vested, and (iii) 500,000 shares of common stock.
Open filing 0001493152-26-047346 Read from the filing’s XML Dispute this row
2026-09-28 Filed 2026-09-30Alila Hector W Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (50,000) — exercise price 1.24
Acquired (A)50,0000—75,000Direct (D) No
F1, F2, F3
  • F1 On September 28, 2026, at the recommendation of the Issuer's Compensation Committee, the Issuer's Board of Directors approved this option grant under the Company's equity incentive plan.
  • F2 The options vested immediately on September 28, 2026.
  • F3 Includes the options previously issued to the Reporting Person.
Open filing 0001493152-26-045006 Read from the filing’s XML Dispute this row
2026-09-28 Filed 2026-09-30Galeta Christopher Matthew Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (25,000) — exercise price 1.24
Acquired (A)25,0000—50,000Direct (D) No
F1, F2, F3
  • F1 On September 28, 2026, at the recommendation of the Issuer's Compensation Committee, the Issuer's Board of Directors approved this option grant under the Company's equity incentive plan.
  • F2 The options vested immediately on September 28, 2026.
  • F3 Includes the options previously issued to the Reporting Person.
Open filing 0001493152-26-044996 Read from the filing’s XML Dispute this row
2026-09-28 Filed 2026-09-30Melton Christopher Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (50,000) — exercise price 1.24
Acquired (A)50,0000—75,000Direct (D) No
F1, F2, F3
  • F1 On September 28, 2026, at the recommendation of the Issuer's Compensation Committee, the Issuer's Board of Directors approved this option grant under the Company's equity incentive plan.
  • F2 The options vested immediately on September 28, 2026.
  • F3 Includes the options previously issued to the Reporting Person.
Open filing 0001493152-26-045002 Read from the filing’s XML Dispute this row
2026-09-28 Filed 2026-09-30Meadows Brian Officer: Chief Financial Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (25,000) — exercise price 1.24
Acquired (A)25,0000—25,000Direct (D) No
F1, F2
  • F1 On September 28, 2026, at the recommendation of the Issuer's Compensation Committee, the Issuer's Board of Directors approved this option grant under the Company's equity incentive plan.
  • F2 The options vested immediately on September 28, 2026.
Open filing 0001493152-26-044990 Read from the filing’s XML Dispute this row
2026-07-23 Filed 2026-07-28John Brian Director · Officer: Interim CFO
J

Other acquisition or disposition (describe transaction)

Common Stock
Disposed (D)150,0001.00
150,000

Derived: shares × price per share. Exact value 150000.00.

600,000Direct (D) No
F1
  • F1 Represents redemption of 150,000 shares of common stock of the Issuer at approximately $1.00 per share pursuant to that certain Share Redemption Agreement dated July, 10, 2026, by and between the Issuer and BK Investments LLC, an entity owned by the Reporting Person, the Issuer's Chairman and Interim Chief Financial Officer.
Open filing 0001493152-26-035004 Read from the filing’s XML Dispute this row
2026-03-27 Filed 2026-03-27WILSON GLYNN Director · Officer: Chief Executive Officer
D

Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Common Stock
Disposed (D)1,500,0000.50
750,000

Derived: shares × price per share. Exact value 750000.00.

672,592Direct (D) No
F1, F2
  • F1 Represents redemption of 1,500,000 shares of common stock of the Issuer at approximately $0.50 per share pursuant to that certain Share Redemption Agreement signed by the Reporting Person and the Issuer on March 19, 2026.
  • F2 The number of shares of common stock beneficially owned following the reported transaction includes Dr. Wilson's ownership of (i) 126,720 restricted stock units of common stock of the Issuer of which zero have vested, (ii) 45,872 restricted stock units of common stock of the Issuer of which zero have vested, and (iii) 500,000 shares of common stock.
Open filing 0001493152-26-013341 Read from the filing’s XML Dispute this row
2026-03-27 Filed 2026-03-27John Brian Director
D

Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Common Stock
Disposed (D)1,250,0001.00
1,250,000

Derived: shares × price per share. Exact value 1250000.00.

750,000Direct (D) No
F1
  • F1 Represents redemption of 1,250,000 shares of common stock of the Issuer at approximately $1.00 per share pursuant to that certain Share Redemption Agreement signed by the Reporting Person and the Issuer on March 19, 2026.
Open filing 0001493152-26-013340 Read from the filing’s XML Dispute this row
2025-12-11 Filed 2025-12-16Alila Hector W Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (25,000) — exercise price 1.13
Acquired (A)25,0000—25,000Direct (D) No
F1, F2
  • F1 On December 11, 2025, at the recommendation of the Issuer's Compensation Committee, the Issuer's Board of Directors approved this option grant under the Company's equity incentive plan.
  • F2 The options vested immediately on December 11, 2025.
Open filing 0001493152-25-027895 Read from the filing’s XML Dispute this row
2025-12-11 Filed 2025-12-15Galeta Christopher Matthew Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (25,000) — exercise price 1.13
Acquired (A)25,0000—25,000Direct (D) No
F1, F2
  • F1 On December 11, 2025, at the recommendation of the Issuer's Compensation Committee, the Issuer's Board of Directors approved this option grant under the Company's equity incentive plan.
  • F2 The options vested immediately on December 11, 2025.
Open filing 0001493152-25-027840 Read from the filing’s XML Dispute this row
2025-12-11 Filed 2025-12-15Moore Tyler Thomas Officer: Chief Financial Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Disposed (D)270,0000—270,000Direct (D) No
F1
  • F1 On December 11, 2025, on recommendation of the Compensation Committee of the Board of Directors (Board) of the Issuer, the Board approved the issuance of 270,000 restricted stock units of common stock of the Issuer, under its equity incentive plan. The RSU shares will fully vest on June 11, 2026. The vesting of shares is subject to Mr. Moore's continued services with the Company.
Open filing 0001493152-25-027836 Read from the filing’s XML Dispute this row
2025-12-11 Filed 2025-12-15Moore Tyler Thomas Officer: Chief Financial Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Disposed (D)30,0000—300,000Direct (D) No
F2
  • F2 On December 11, 2025, on recommendation of the Compensation Committee of the Board of the Issuer, the Board approved the issuance of 30,000 restricted stock units of common stock of the Issuer, under its equity incentive plan. The RSU shares will fully vest on December 11, 2026. The vesting of shares is subject to Mr. Moore's continued service with the Company.
Open filing 0001493152-25-027836 Read from the filing’s XML Dispute this row
2025-12-11 Filed 2025-12-15Melton Christopher Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (25,000) — exercise price 1.13
Acquired (A)25,0000—25,000Direct (D) No
F1, F2
  • F1 On December 11, 2025, at the recommendation of the Issuer's Compensation Committee, the Issuer's Board of Directors approved this option grant under the Company's equity incentive plan.
  • F2 The options vested immediately on December 11, 2025.
Open filing 0001493152-25-027842 Read from the filing’s XML Dispute this row
2025-12-11 Filed 2025-12-15WILSON GLYNN Director · Officer: Chief Executive Officer · 10% owner
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Disposed (D)126,7200—2,126,720Direct (D) No
F1, F3
  • F1 On December 11, 2025, on recommendation of the Compensation Committee of the Board of Directors (Board) of the Issuer, the Board approved the issuance of 126,720 restricted stock units of common stock of the Issuer, under its equity incentive plan. The RSU shares will fully vest on June 11, 2026. The vesting of shares is subject to Dr. Wilson's continued services with the Company.
  • F3 The number of shares of common stock beneficially owned following the reported transactions includes Dr. Wilson's ownership of 2,000,000 shares of common stock.
Open filing 0001493152-25-027838 Read from the filing’s XML Dispute this row
2025-12-11 Filed 2025-12-15WILSON GLYNN Director · Officer: Chief Executive Officer · 10% owner
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Disposed (D)45,8720—2,172,592Direct (D) No
F2, F3
  • F2 On December 11, 2025, on recommendation of the Compensation Committee of the Board of the Issuer, the Board approved the issuance of 45,872 restricted stock units of common stock of the Issuer, under its equity incentive plan. The RSU shares will fully vest on December 11, 2026. The vesting of shares is subject to Dr. Wilson's continued service with the Company.
  • F3 The number of shares of common stock beneficially owned following the reported transactions includes Dr. Wilson's ownership of 2,000,000 shares of common stock.
Open filing 0001493152-25-027838 Read from the filing’s XML Dispute this row
2025-12-11 Filed 2025-12-15John Brian Director · 10% owner
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (100,000) — exercise price 1.243
Acquired (A)100,0000—100,000Direct (D) No
F1, F2, F3
  • F1 On December 11, 2025, at the recommendation of the Issuer's Compensation Committee, the Issuer's Board of Directors approved the grant of 100,000 options, under the Company's equity incentive plan.
  • F2 The options shall fully vest on June 11, 2026. Vesting of options is subject to the Reporting Person's continued services with the Issuer.
  • F3 Does not include the 2,000,000 shares of common Stock of the Issuer owned by the Reporting Person.
Open filing 0001493152-25-027850 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 8,925 filings read, the latest filed 2026-11-19. Prior quarter ending 2026-06-30: 9,176 filings read.

Showing 1–9 of 9

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
LPL Financial LLC 135,394 SH161,119 dollarsHigher by 125,394 Prior quarter: 10,000Open filing 0001403438-26-000005 Filed 2026-11-06 Dispute this row
VANGUARD CAPITAL MANAGEMENT LLC 26,155 SH31,124 dollarsUnchanged Prior quarter: 26,155Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row
GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager24,849 SH29,569 dollarsLower by 87 Prior quarter: 24,936Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row
CITADEL ADVISORS LLC Partly reported under another manager20,180 SH24,014 dollarsNot in the prior quarter’s filings read Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row
JANE STREET GROUP, LLC Partly reported under another manager15,834 SH18,842 dollarsHigher by 187 Prior quarter: 15,647Open filing 0001595888-26-000162 Filed 2026-11-12 Dispute this row
UBS Group AG Partly reported under another manager10,459 SH12,446 dollarsHigher by 6,936 Prior quarter: 3,523Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row
Tower Research Capital LLC (TRC) Partly reported under another manager563 SH670 dollarsLower by 1,896 Prior quarter: 2,459Open filing 0001533421-26-000010 Filed 2026-11-16 Dispute this row
BARCLAYS PLC Partly reported under another manager11 SH14 dollarsNot in the prior quarter’s filings read Open filing 0000312069-26-000241 Filed 2026-11-06 Dispute this row
Caitong International Asset Management Co., Ltd 7 SH8 dollarsHigher by 6 Prior quarter: 1Open filing 0001628280-26-068135 Filed 2026-10-29 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • FRANKLIN RESOURCES INC 35,970 SH
  • SUSQUEHANNA INTERNATIONAL GROUP, LLP 20,771 SH
  • XTX Topco Ltd 18,484 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • Reports for quarters ending before 2013-06-30 were filed as plain text and are not read.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

No Schedule 13D or 13G naming this issuer is in the store; this is not a statement that none were filed.

What was read

2,671,519 filings read, dated 2004-06-14 to 2026-11-19: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
201588,606
2016222,642
2017222,009
2018223,345
2019216,482
2020226,343
2021249,835
2022231,682
2023229,674
2024234,045
2025235,520
2026263,123

Filings made before the SEC required XML are listed, not extracted.

Back to CARING BRANDS, INC.